Log in to search using one of your social media accounts:

 

Transgender female wrestler taking steroids to become MALE wins championship against girls... lawsuits fly
(Natural News) This past weekend, 17-year-old Mack Beggs emerged victorious in the girls’ 110-pound Class 6A Region 2 wrestling championship at Allen High School in North Texas. The only problem? Beggs is a female to male transgender student who has been receiving testosterone injections, thus raising concerns over the fairness of Begg’s participation in the... (Source: NaturalNews.com)
Source: NaturalNews.com - February 21, 2017 Category: Consumer Health News Source Type: news

DEPO-TESTOSTERONE (Testosterone Cypionate) Injection, Solution [Pharmacia And Upjohn Company LLC]
Updated Date: Jan 23, 2017 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - January 23, 2017 Category: Drugs & Pharmacology Source Type: news

MEDICAL BREAKTHROUGH: Prostate cancer cured with high dose testosterone injections
PROSTATE cancer could be treated by shocking tumours with testosterone after a man with the advanced stage of the disease was cured. (Source: Daily Express - Health)
Source: Daily Express - Health - December 1, 2016 Category: Consumer Health News Source Type: news

DEPO-TESTOSTERONE (Testosterone Cypionate) Injection, Solution [Pharmacia And Upjohn Company LLC]
Updated Date: Sep 21, 2016 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - September 21, 2016 Category: Drugs & Pharmacology Source Type: news

Depo-Testosterone (Testosterone Cypionate Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 10, 2016 Category: Drugs & Pharmacology Source Type: news

Is testosterone the key to weight loss?
Scientists from University of Melbourne gave 49 dieting obese men testosterone injections, and 51 placebo, and found those taking hormone therapy lost more weight overall - but not muscle. (Source: the Mail online | Health)
Source: the Mail online | Health - April 5, 2016 Category: Consumer Health News Source Type: news

UTMB study shows testosterone therapy does not increase aggressive prostate cancer risk
(University of Texas Medical Branch at Galveston) A new population-based study from The University of Texas Medical Branch at Galveston showed for the first time that exposure to testosterone therapy over a five-year period was not associated with an increased risk of aggressive prostate cancer. Further, risk of high-grade prostate cancer did not increase according to the total number of testosterone injections. The study is available in the Journal of Urology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 5, 2015 Category: Global & Universal Source Type: news

Testosterone injections, not gels, increase CV event risk
Greater risks for cardiovascular events, hospitalisation and death were found with testosterone injections compared with gels, according to study findings published in JAMA Internal Medicine. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 4, 2015 Category: Endocrinology Source Type: news

Depo-Testosterone (Testosterone Cypionate Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 28, 2015 Category: Drugs & Pharmacology Source Type: news

Study rates safety of different testosterone preparations
Short-acting testosterone injections are associated with greater risk of cardiovascular events, hospitalizations, and death compared with gels or patches, according to a large retrospective cohort study published online in JAMA Internal Medicine. MedPage Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 14, 2015 Category: Endocrinology Source Type: news

Testosterone Drugs May Be Overused, FDA Warns
WASHINGTON (AP) — The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related issues like low libido and fatigue. The agency says drugmakers must clearly state in their labeling and promotions that the drugs, currently taken by millions of U.S. men, are only approved to treat low testosterone levels caused by disease or injury, not normal aging. Additionally, the FDA cautioned that the drugs may increase the risk of heart attack, stroke and other cardiovascular pro...
Source: Science - The Huffington Post - March 3, 2015 Category: Science Source Type: news

DEPO-TESTOSTERONE (Testosterone Cypionate) Injection, Solution [A-S Medication Solutions LLC]
Updated Date: Dec 22, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - December 22, 2014 Category: Drugs & Pharmacology Source Type: news

DEPO-TESTOSTERONE (Testosterone Cypionate) Injection, Solution [A-S Medication Solutions LLC]
Updated Date: Oct 14, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - October 14, 2014 Category: Drugs & Pharmacology Source Type: news

Testosterone Treatment Lawsuit News: New Filing Alleges...
The Firm is evaluating testosterone lawsuits on behalf of men who suffered serious cardiovascular events, allegedly due to their use of Depo-Testosterone and other prescription low testosterone...(PRWeb August 22, 2014)Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/depo-testosterone-lawsuit/prweb12115284.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 23, 2014 Category: Pharmaceuticals Source Type: news

Delatestryl (Testosterone Enanthate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 7, 2014 Category: Drugs & Pharmacology Source Type: news

DEPO-TESTOSTERONE (Testosterone Cypionate) Injection, Solution [Pharmacia And Upjohn Company]
Updated Date: Jul 1, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - July 1, 2014 Category: Drugs & Pharmacology Source Type: news

DELATESTRYL (Testosterone Enanthate) Injection, Solution [Endo Pharmaceuticals Solutions Inc.]
Updated Date: Jul 1, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - July 1, 2014 Category: Drugs & Pharmacology Source Type: news

DEPO-TESTOSTERONE (Testosterone Cypionate) Injection, Solution [Pharmacia And Upjohn Company]
Updated Date: Jun 23, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - June 23, 2014 Category: Drugs & Pharmacology Source Type: news

Low Testosterone Lawsuits Transferred to Federal Multidistrict...
All Pending and Future Testosterone Lawsuits Filed in Federal Courts Involving AndroGel, Axiron, Testim, Foresta, AndroDerm and Depo-Testosterone Will be Transferred to the U.S. District Court,...(PRWeb June 18, 2014)Read the full story at http://www.prweb.com/releases/2014/06/prweb11949048.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 19, 2014 Category: Pharmaceuticals Source Type: news

Low Testosterone Lawsuits Transferred to Federal Multidistrict...
All Pending and Future Testosterone Lawsuits Filed in Federal Courts Involving AndroGel, Axiron, Testim, Foresta, AndroDerm and Depo-Testosterone Will be Transferred to the U.S. District Court,...(PRWeb June 10, 2014)Read the full story at http://www.prweb.com/releases/2014/06/prweb11930045.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 10, 2014 Category: Pharmaceuticals Source Type: news

DEPO-TESTOSTERONE (Testosterone Cypionate) Injection, Solution [Pharmacia And Upjohn Company]
Updated Date: May 2, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - May 2, 2014 Category: Drugs & Pharmacology Source Type: news

Endo's Testosterone Injection Finally Wins FDA Nod
(MedPage Today) -- Testosterone undecanoate for injection (Aveed) has received the FDA's approval for treating male hypogonadism on its third try, its manufacturer announced. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - March 6, 2014 Category: Geriatrics Source Type: news

Mother is diagnosed with cancer on her NECK after taking her son to the doctors over worrying spot on his head
Marie Testro, 43, from Derby, took her son Billy to their family GP after she became worried about a spot on his hairline. (Source: the Mail online | Health)
Source: the Mail online | Health - January 23, 2014 Category: Consumer Health News Source Type: news

FDA Rejects Long-Acting Testosterone Injection for Third TimeFDA Rejects Long-Acting Testosterone Injection for Third Time
In a decision that will surprise few people, the FDA has once again refused approval for long-acting testosterone undecanoate injection for male hypogonadism. FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 31, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news

DEPO-TESTOSTERONE (Testosterone Cypionate) Injection, Solution [A-S Medication Solutions LLC]
Updated Date: May 2, 2013 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - May 2, 2013 Category: Drugs & Pharmacology Source Type: news

FDA staff concerned about safety of Endo's testosterone injection
(Reuters) - Reviewers for the U.S. Food and Drug Administration said safety data on Endo Health Solutions Inc's twice-rejected testosterone injection Aveed was "concerning" and showed that the therapy was associated with severe and immediate post-injection adverse events. (Source: Reuters: Health)
Source: Reuters: Health - April 16, 2013 Category: Consumer Health News Tags: healthNews Source Type: news